I wrote a short editorial on hyponatremia and it's effect on mortality for eAJKD. I like the comparison of tolvaptan to Epo. Hopefully we will not have to wait two decades for a properly done RCT with patient oriented outcomes. We know the drug raises the sodium, now let's see if it reduces fractures, falls and mortality.Thursday, August 1, 2013
An editorial on hyponatremia
I wrote a short editorial on hyponatremia and it's effect on mortality for eAJKD. I like the comparison of tolvaptan to Epo. Hopefully we will not have to wait two decades for a properly done RCT with patient oriented outcomes. We know the drug raises the sodium, now let's see if it reduces fractures, falls and mortality.
